Effects of tamoxifen on serotonin transporter and 5- hydroxytryptamine(2A) receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement

Molecular Brain Research

Volumn 73, Issue 1-2, 1999, Pages 119-128

  Sumner, Barbara E H ^a   Grant, Kay E ^a   Rosie, Roberta ^a   Hegele Hartung, Ch ^b   Fritzemeier, K H ^b   Fink, George ^a  

^a ROYAL EDINBURGH HOSPITAL   (United Kingdom)

^b BAYER PHARMA AG   (Germany)

Author keywords

5 Hydroxytryptamine(2A) receptor; Estradiol receptor; Estradiol 17 ; Serotonin transporter; Tamoxifen

Indexed keywords

ESTRADIOL; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; TAMOXIFEN;

ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; BRAIN; COGNITION; DRUG EFFECT; FEMALE; FOREBRAIN; MENTAL HEALTH; MOOD; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RNA ANALYSIS; SEROTONINERGIC SYSTEM;

ANIMALS; BINDING SITES; BINDING, COMPETITIVE; BRAIN; CARRIER PROTEINS; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN REPLACEMENT THERAPY; FEMALE; IN SITU HYBRIDIZATION; LUTEINIZING HORMONE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; ORGAN SIZE; OVARIECTOMY; RADIOLIGAND ASSAY; RAPHE NUCLEI; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; RNA, MESSENGER; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TAMOXIFEN; TRITIUM; UTERUS;

ANIMALIA;

EID: 0032719205     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(99)00243-0     Document Type: Article

References (58)

1. Aghajanian G.K., Marek G.J. Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology. 36:1997;589-599.
2. Aiyer M.S., Fink G. The role of sex steroid hormones in modulating the responsiveness of the anterior pituitary gland to luteinizing hormone releasing factor in the female rat. J. Endocrinol. 62:1974;553-572.
3. Alves S.E., Weiland N.G., Hayashi S., McEwen B.S. Immunocytochemical localization of nuclear estrogen receptors and progestin receptors within the rat dorsal raphe nucleus. J. Comp. Neurol. 391:1998;322-334.
4. Alves S.E., Weiland N.G., Lopez V., McEwen B.S. Phenotypic identification of ovarian steroid target cells in the rodent dorsal raphe and central gray. Soc. Neurosci. Abstr. 24:1998;436.1.
5. Barkhem T., Carlsson B., Nilsson Y., Enmark E., Gustafsson J.-A. Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/antagonists. Mol. Pharmacol. 54:1998;105-112.
6. Berry M., Metzger D., Chambon P. Role of the two activating domains of the estrogen receptor in the cell-type and promoter-context-dependent agonist activity of the anti-estrogen 4-hydroxytamoxifen. EMBO J. 9:1990;2811-2818.
7. Biegon A., Reches A., Snyder L., McEwen B.S. Serotonergic and noradrenergic receptors in the rat brain: modulation by chronic exposure to ovarian hormones. Life Sci. 32:1983;2015-2021.
8. Brace M., McCauley E. Oestrogens and psychological well-being. Ann. Med. 29:1997;283-290.
9. Brzozowski A.M., Pike A.C.W., Dauter Z., Hubbard R.E., Bonn T., Engström O., Ohman L., Greene G.L., Gustafsson J.-A., Carlquist M. Molecular basis of agonism and antagonism in the estrogen receptor. Nature. 389:1997;753-758.
10. Cathcart C.K., Jones S.E., Pumroy C.S., Peters G.N., Knox S.M., Cheek J.H. Clinical recognition and management of depression in node negative breast cancer patients treated with tamoxifen. Breast Cancer Res. Treat. 27:1993;277-281.
11. Cheskis B.J., Karathanasis S., Lyttle C.R. Estrogen receptor ligands modulate its interaction with DNA. J. Biol. Chem. 272:1997;11384-11391.
12. 2A receptors: emphasis on the rat frontal cortex. Neuroscience. 83:1998;829-836.
13. Dipippo V.A., Lindsay R., Powers A.C. Estradiol and tamoxifen interactions with thyroid hormone in the ovariectomized-thyroidectomized rat. Endocrinology. 136:1995;1020-1033.
14. Donath J., Nishino Y. Effects of partial versus pure antiestrogens on ovulation and the pituitary-ovarian axis in the rat. J. Steroid Biochem. Mol. Biol. 66:1998;247-254.
15. 3H ]citalopram binding in rat and human brain: species differences and relationships to serotonin innervation patterns Brain Res. 591:1992;181-197.
16. G. Fink, The psychoprotective action of estrogen is mediated by central serotonergic as well as dopaminergic mechanisms, in: A. Takada, G. Curzon (Eds.), Serotonin in the Central Nervous System and Periphery, Elsevier, Amsterdam, 1995, pp. 175-187.
17. 2A receptors important for the oestradiol-induced surge of luteinizing hormone-releasing hormone in the rat. J. Neuroendocrinol. 11:1999;63-69.
18. Fink G., Sumner B.E.H. Oestrogen and mental state. Nature. 383:1996;306.
19. Fink G., Sumner B.E.H., McQueen J.K., Wilson H., Rosie R. Sex steroid control of mood, mental state and memory. Clin. Exp. Pharmacol. Physiol. 25:1998;764-775.
20. Frankfurt M., McKittrick C.R., Mendelson S.D., McEwen B.S. Effect of 5,7-dihydroxytryptamine, ovariectomy and gonadal steroids on serotonin receptor binding in rat brain. Neuroendocrinology. 59:1994;245-250.
21. Goldberg R.M., Loprinzi C.L., O'Fallon J.R., Veeder M.H., Miser A.W., Mailliard J.A., Michalak J.C., Dose A.M., Rowland K.M., Burnham N.L. Transdermal clonidine for ameliorating tamoxifen-induced hot flushes. J. Clin. Oncol. 12:1994;155-158.
22. Grese T.A., Sluka J.P., Bryant H.U., Cullinan G.J., Glasebrook A.L., Jones C.D., Matsumoto K., Palkowitz A.D., Sato M., Termine J.D., Winter M.A., Yang N.N., Dodge J.A. Molecular determinants of tissue selectivity in estrogen receptor modulators. Proc. Natl. Acad. Sci. U.S.A. 94:1997;14105-14110.
23. Halbreich H. Role of estrogen in postmenopausal depression. Neurology. 48:1997;S16-S20.
24. Haskell S.G., Richardson E.D., Horwitz R.I. The effect of estrogen replacement therapy on cognitive function in women: a critical review of the literature. J. Clin. Epidemiol. 50:1997;1249-1264.
25. Hiemke C., Poetz B., Ghraf G. Antiestrogen inhibition of estradiol-induced alterations in hypothalamic noradrenaline turnover. J. Endocrinol. 106:1985;37-42.
26. 2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc. Natl. Acad. Sci. U.S.A. 95:1998;735-740.
27. Joffe H., Cohen L.S. Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge? Biol. Psychiatry. 44:1998;798-811.
28. Jolas T., Aghajanian G.K. Opioids suppress spontaneous and NMDA-induced inhibitory postsynaptic currents in the dorsal raphe nucleus of the rat in vitro. Brain Res. Bull. 755:1997;229-245.
29. Jordan V.C., Phelps E., Lindgren J.V. Effects of antiestrogens on bone in castrated and intact female rats. Breast Cancer Res. Treat. 10:1987;31-35.
30. Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J.A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U.S.A. 93:1996;5925-5930.
31. Kuiper G.G.J.M., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., Gustafsson J.-A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 138:1997;863-870.
32. Logie C., Nichols M., Myles K., Funder J.W., Stewart A.F. Positive and negative discrimination of estrogen receptor agonists and antagonists using site-specific DNA recombinase fusion proteins. Mol. Endocrinol. 12:1998;1120-1132.
33. 3H -RP 62203 binding in the rat brain Eur. J. Pharmacol. 233:1993;37-45.
34. McInerney E.M., Katzenellenbogen B.S. Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation. J. Biol. Chem. 271:1996;24172-24178.
35. McQueen J.K., Wilson H., Fink G. Estradiol-17β increases serotonin transporter (SERT) mRNA levels and the density of SERT binding sites in female rat brain. Mol. Brain Res. 45:1997;13-23.
36. McQueen J.K., Wilson H., Sumner B.E.H., Fink G. Serotonin transporter (SERT) mRNA and binding site densities in male rat brain affected by sex steroids. Mol. Brain Res. 63:1999;241-247.
37. Mosselman S., Polman J., Dijkema R. ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett. 392:1996;49-53.
38. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, 4th edn., Academic Press, San Diego, 1998, 276 pp.
39. Pecins-Thompson M., Brown N.A., Bethea C.L. Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. Mol. Brain Res. 53:1998;120-129.
40. Sadovsky Y., Adler S. Editorial: selective modulation of estrogen receptor action. J. Clin. Endocrinol. Metab. 83:1998;3-5.
41. Sato M., Rippy M.K., Bryant H.U. Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and non-reproductive tissues in ovariectomized rats. FASEB J. 10:1996;905-912.
42. Schmale H., Heinsohn S., Richter D. Structural organization of the rat gene for the arginine vasopressin-neurophysin precursor. EMBO J. 2:1983;763-767.
43. Fluoxetine Collaborative Study Group, Schneider L.S., Small G.W., Hamilton S.H., Bystritsky A., Nemeroff C.B., Meyers B.S. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Am. J. Geriatr. Psychiatry. 5:1997;97-106.
44. Shariff S., Cumming C.E., Lees A., Handman M., Cumming D.C. Mood disorder in women with early breast cancer taking tamoxifen, an estradiol receptor antagonist. An expected or unexpected effect? Ann. N.Y. Acad. Sci. 761:1995;365-368.
45. Sherwood N.M., Chiappa S.A., Fink G. Immunoreactive luteinizing hormone releasing factor in pituitary stalk blood from female rats; sex steroid modulation of response to electrical stimulation of preoptic area or median eminence. J. Endocrinol. 70:1976;501-511.
46. Shughrue P.J., Lane M.V., Merchenthaler I. Comparative distribution of estrogen receptor-α and -β mRNA in the rat central nervous system. J. Comp. Neurol. 388:1997;507-525.
47. Stahl S.M. Augmentation of antidepressants by estrogen. Psychopharmacol. Bull. 34:1998;319-321.
48. Stahl S.M. Basic psychopharmacology of antidepressants: 2. Estrogen as an adjunct to antidepressant treatment. J. Clin. Psychiatry. 59:1998;15-24.
49. Studd J., Leather A.T. The need for add-back with gonadotrophin-releasing hormone agonist therapy. Br. J. Obstet. Gynecol. 103:1996;1-4.
50. Sumner B.E.H., Fink G. Effects of acute estradiol on 5-hydroxytryptamine and dopamine receptor subtype mRNA expression in female rat brain. Mol. Cell. Neurosci. 4:1993;83-92.
51. 2A receptors in cerebral cortex and nucleus accumbens in the female rat. J. Steroid Biochem. Mol. Biol. 54:1995;15-20.
52. 2A receptor mRNA and binding site densities in the male rat brain. Mol. Brain Res. 59:1998;205-214.
53. Sumner B.E.H., Rosie R., Fink G. Relative density of 5-hydroxytryptamine receptor subtype mRNAs in female rat neuroendocrine brain determined by in situ hybridization histochemistry. Mol. Cell. Neurosci. 3:1992;215-223.
54. Tremblay G.B., Tremblay A., Copeland N.G., Gilbert D.J., Jenkins N., Labrie F., Giguere V. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta. Mol. Endocrinol. 11:1997;353-365.
55. Warnock J.K., Bundren J.C. Anxiety and mood disorders associated with gonadotropin-releasing hormone agonist therapy. Psychopharmacol. Bull. 33:1997;311-316.
56. Warnock J.K., Bundren J.C., Morris D.W. Depressive symptoms associated with gonadotropin-releasing hormone agonists. Depression and Anxiety. 7:1998;171-177.
57. Yang N.N., Venugopalan M., Hardikar S., Glasebrook A. Identification of an estrogen response element activated by metabolites of 17β-estradiol and raloxifene. Science. 273:1996;1222-1225.
58. Young E., Korszun A. Psychoneuroendocrinology of depression. Psychoneuroendocrinology. 21:1998;309-323.